This program was filmed during the year 2000 and covers the
first clinical trials of Endostatin in human patients. As of
March 2002, 120 patients have received Endostatin, with no
side effects reported. There has also been enough biological
effect to justify continued testing. Today, taking
Endostatin is much simpler than it was when the film was
produced. Many patients are self-injecting at home, as
diabetics do with insulin. The next phase of testing, which
will begin to assess how effective Endostatin is against
cancer.
After six months, Duane Gay was removed from the Endostatin
clinical trial.
His tumors had grown beyond the strict limit allowed by the
University of Wisconsin's Endostatin protocol.
He continues to battle his cancer with experimental
therapies and hopes to get back on Endostatin when a new
protocol is available.
